Deal Details

Initial Public Offering

---

Summary

About

Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) recently completed an initial public offering of 238,050,000 shares of common stock at $14.00 per share, generating gross proceeds of approximately $3,333 million, which included the exercise in full by the underwriters of their option to purchase additional shares of common stock on the same terms and conditions. Avantor also completed a concurrent offering of 20,700,000 shares of 6.250% Series A Mandatory Convertible Preferred Stock priced at $50.00 per share, generating gross proceeds of $1,035 million, which included the exercise in full by the underwriters of their option to purchase additional shares of mandatory convertible preferred stock on the same terms and conditions. The Company intends to use the net proceeds to redeem all outstanding shares of existing senior preferred stock and to repay outstanding indebtedness on the Company’s Dollar Term and Euro Term loan facilities.

Avantor is a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government and advanced technologies & applied materials industries. The Company’s comprehensive offerings, which include materials & consumables, equipment & instrumentation and services & specialty procurement, are relied upon by its customers because Avantor’s solutions are frequently specified into their research, development and production processes. Avantor collaborates closely with its customers to enable them to develop new innovative products, improve product or process performance characteristics and enhance the safety of the drugs, devices and other products they produce. The Company’s local presence combined with its global infrastructure enable successful relationships with its customers and connects Avantor to over 240,000 of their locations in over 180 countries. Avantor is headquartered in Radnor, Pennsylvania.

---

CONTACT US TO LEARN MORE